Tier 3 Drug Shortages
Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:
- a review of the information gathered on the shortage issue, and
- a thorough discussion on its potential impact and next steps.
Below are the newest and most recently updated active ingredients that have been designated as Tier 3 shortages. Click on the active ingredient to see a list of the associated Tier 3 drug shortage and/or discontinuation reports.
Active Ingredient
23 active ingredients found
Abatacept solution for subcutaneous injection
solution |
Alprostadil Sterile Solution
solution |
Aminophylline
solution |
Apomorphine Hydrochloride
solution |
Apomorphine Hydrochloride
film, soluble |
ARGATROBAN
solution |
ASPARAGINASE - ERWINASE
powder for solution |
BUPIVACAINE HYDROCHLORIDE
solution |
CALCITONIN
solution |
Calcium Chloride Injection
solution |
Calcium Chloride Injection
liquid |
CHOLESTYRAMINE RESIN
powder for suspension |
CISATRACURIUM
solution |
COLESEVELAM HYDROCHLORIDE
tablet |
COLESEVELAM HYDROCHLORIDE
powder for suspension |
COLESTIPOL
granules |
DEXTROSE INJECTION
solution |
Dipyridamole Injection
liquid |
Dipyridamole Injection
solution |
Eluxadoline
tablet |